Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Marotti

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 15, 2006
Background to Eusoma guidelines and statementsM Greco, L Marotti,
Ecancermedicalscience|January 26, 2012
To know or not to know? Not the only question in familial breast cancer risk communicationC Maddock, D Schrijvers, Mrd Turco, et al.
Breast (Edinburgh, Scotland)|February 1, 2019
EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implantsM J Cardoso, L Wyld, I T Rubio, et al.
Breast (Edinburgh, Scotland)|November 11, 2019
Corrigendum to "EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants" [Breast 44 (April 2019) 90-93]M J Cardoso, L Wyld, I T Rubio, et al.
Breast (Edinburgh, Scotland)|November 11, 2019
Corrigendum to "About the French prohibition of textured breast implants: Is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position" [Breast 46 (August 2019) 95-96]M J Cardoso, L Biganzoli, I T Rubio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 15, 2019
Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international surveyI T Rubio, L Wyld, A Esgueva, et al.
Breast (Edinburgh, Scotland)|June 28, 2026
What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT studyA De Luca, M I Amabile, M Tomatis, et al.
Breast (Edinburgh, Scotland)|September 6, 2024
Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022A De Luca, M I Amabile, F Santori, et al.
Breast (Edinburgh, Scotland)|June 27, 2025
Corrigendum to "Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022" [The Breast 78 (2024) 103790]A De Luca, M I Amabile, F Santori, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimizationG Curigliano, L Marotti, C Barrios, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|August 15, 2006
Background to Eusoma guidelines and statementsM Greco, L Marotti,
Ecancermedicalscience|January 26, 2012
To know or not to know? Not the only question in familial breast cancer risk communicationC Maddock, D Schrijvers, Mrd Turco, et al.
Breast (Edinburgh, Scotland)|February 1, 2019
EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implantsM J Cardoso, L Wyld, I T Rubio, et al.
Breast (Edinburgh, Scotland)|November 11, 2019
Corrigendum to "EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants" [Breast 44 (April 2019) 90-93]M J Cardoso, L Wyld, I T Rubio, et al.
Breast (Edinburgh, Scotland)|November 11, 2019
Corrigendum to "About the French prohibition of textured breast implants: Is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position" [Breast 46 (August 2019) 95-96]M J Cardoso, L Biganzoli, I T Rubio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 15, 2019
Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international surveyI T Rubio, L Wyld, A Esgueva, et al.
Breast (Edinburgh, Scotland)|June 28, 2026
What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT studyA De Luca, M I Amabile, M Tomatis, et al.
Breast (Edinburgh, Scotland)|September 6, 2024
Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022A De Luca, M I Amabile, F Santori, et al.
Breast (Edinburgh, Scotland)|June 27, 2025
Corrigendum to "Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022" [The Breast 78 (2024) 103790]A De Luca, M I Amabile, F Santori, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimizationG Curigliano, L Marotti, C Barrios, et al.
Pageof 2